Applied DNA Sciences Signs Business Development and Trademark License Agreement with Dr. Suwelack Skin & Healthcare AG
May 09 2006 - 8:35AM
PR Newswire (US)
STONY BROOK, N.Y., May 9 /PRNewswire-FirstCall/ -- Applied DNA
Sciences, Inc. (OTC:APDN) (BULLETIN BOARD: APDN) , a DNA security
solutions company, announced that it signed an agreement with Dr.
Suwelack Skin & Healthcare AG ("Suwelack") providing Suwelack
rights to use APDN's SigNature(TM) logo, which is printed with ink
containing our proprietary encrypted botanical DNA technology, and
to participate in its SigNature(TM) Program. The terms of this one
year license agreement provide Suwelack with a limited,
non-exclusive, non-transferable right to use the SigNature(TM) logo
on its packaging and labels. Created by APDN, the goal of the
SigNature(TM) Program is to provide a secure, cost effective and
forensic method to help companies like Suwelack protect their
intellectual property assets and the value of their brand. This
program is based on APDN's proprietary platform technology whereby
nanoscopic botanical DNA is embedded in a proprietary protective
coating that withstands commercial processing and gives DNA a life
of several hundred years. Botanical DNA will be embedded into the
ink that will be used in the SigNature(TM) logo utilizing both
overt and covert DNA security technologies. This botanical DNA can
later be sequenced and decoded from the SigNature(TM) logo to
verify the authenticity of Suwelack's products. Suwelack is
recognized in Germany as the leader in the innovation, development
and manufacture of biomatrices for cosmeceutical and healthcare
applications. Suwelack has adopted the SigNature(TM) Program as one
of many new initiatives that complement its expansion into the
North American market. According to Nikolaus Uleer, Chief Executive
Officer of Suwelack, "We are very pleased to utilize DNA encryption
technology in our packaging. It provides a secure, forensic, and
most importantly, cost effective approach, that we believe will
provide a positive contribution to the development of our brand."
The SigNature(TM) Program is the first initiative by APDN to
introduce to the market a range of ready-to-use security solutions
aimed at brand protection and authentication, and addressing the
global need to combat counterfeit and piracy. Dr. Benjamin Liang,
Chief Scientist of Applied DNA Sciences, said, "We believe that our
technology provides an immediate benefit and relevance to a company
like Suwelack that has applications in both skincare and
healthcare. From a business development perspective, we can deliver
a fast-track security solution intended to provide both strategic
and tactical value to our clients. We are pleased that Suwelack is
our first commercial partner in Europe." About Dr. Suwelack Skin
& Healthcare AG Dr. Suwelack Skin & Healthcare AG
manufactures biomatrices for skin and healthcare for cosmeceutical
and medical applications. Suwelack's patented technology uses a
freeze-drying process to gently extract water from natural raw
materials, as a result of which the raw materials are preserved in
a highly pure form. By using this technique the company is able to
avoid using preservative agents, chemical cross-linking agents and
perfumes and ensure the basis for skin compatibility. About Applied
DNA Sciences, Inc. Applied DNA Sciences, Inc. (APDN) develops
proprietary DNA-embedded security solutions that use plant DNA to
verify authenticity and protect corporate and government agencies
from counterfeiting, fraud, piracy, product diversion, identity
theft and unauthorized intrusion into physical plant and databases.
Our common stock is listed on the Over-The-Counter Bulletin Board
under the symbol "APDN". The statements made by Applied DNA
Sciences, Inc. in this press release may be forward-looking in
nature and are made pursuant to the safe harbor provisions of the
Private Securities Litigation Reform Act of 1995. Such
forward-looking statements describe the Company's future plans,
projections, strategies and expectations, and may be identified by
words such as "expects," "anticipates," "intends," "plans,"
"believes," "seeks," "estimates" or words of similar meaning. These
forward-looking statements are based on assumptions and involve a
number of risks, uncertainties, situations and other factors that
may cause our or our industry's actual results, level of activity,
performance or achievements to be materially different from any
future results, level of activity, performance or achievements
expressed or implied by these statements. These factors include
changes in interest rates, market competition, changes in the local
and national economies, and various other factors detailed from
time to time in Applied DNA Sciences' SEC reports and filings,
including our Annual Report on Form 10-KSB, filed on January 12,
2006, and subsequent Quarterly Reports on Form 10-QSB and Current
Reports on Form 8-K. The Company undertakes no obligation to update
publicly any forward-looking statements to reflect new information,
events or circumstances after the date hereof to reflect the
occurrence of unanticipated events. DATASOURCE: Applied DNA
Sciences, Inc. CONTACT: MeiLin Wan of Applied DNA Sciences, Inc.,
+1-631-444-6861, or Fax: +1-631-444-8848, Email: ; Nikolaus Uleer,
Dr. Suwelack Skin & Healthcare AG, Josef-Suwelack-Strasse, Tel:
+49-2543-72-247, Fax: +49-2543-72-365 Web site:
http://www.adnas.com/ http://www.skin-healthcare.com/
Copyright